INTRODUCTION
Platelets contain a mitogen, termed the plateletderived growth factor (PDGF),' which stimulates the proliferation of a variety of cell types in culture in vitro (1) . Recent studies, with human platelets, have demonstrated that PDGF is localized in the platelet agranule (2) (3) (4) , and that PDGF is secreted along with other a-granule constituents after stimulation with thrombin, arachidonic acid, and collagen (2, 5) . Interest in PDGF stems from its possible role in the pathogenesis of atherosclerosis (6, 7) , and the more general 1 Abbreviations used in this paper: FCS, fetal calf serum; PDGF, platelet-derived growth factor; PPP, platelet-poor plasma. 926 role that it may play in regulating cell proliferation in concert with plasma-derived proteins.
No information is available about the origin of the PDGF found in circulating platelets. Three general possibilities exist. The first, that PDGF is synthesized in situ in platelets, is unlikely, because platelets have little protein synthetic capacity (8, 9) . A second possibility is that PDGF is derived from outside the platelet, but then taken up by and concentrated within the platelet. A third, more likely possibility is that PDGF is synthesized in conjunction with agranule formation in the megakaryocyte. Megakaryocytes are known to be active in protein synthesis, and previous studies demonstrated that isolated guinea pig megakaryocytes, maintained in short-term culture, synthesize coagulation Factor VIII antigen, which is also found in guinea pig platelets (10) . We now report studies on the presence and quantity of growth factor activity in purified guinea pig megakaryocytes that suggest that PDGF originates in that cell.
METHODS
Healthy Hartley strain guinea pigs were bled by cardiac puncture. Blood was drawn gently into a syringe containing one-ninth as much (by volume) Na citrate-citric acid solution, and was centrifuged at 1,200 g for 15 min at 20°C to obtain platelet-rich plasma. Platelet-rich plasma was centrifuged at 10,000 g for 30 min at 4°C to obtain a platelet pellet and platelet-poor plasma (PPP). The pelleted platelets were washed once by gentle suspension in phosphate-buffered saline, and were again pelleted and stored frozen at -70°C until assayed.
Bone marrow cells were harvested from the femora and humeri of the same guinea pigs (above), into calcium-and magnesium-free Hanks' solution containing citrate, adenosine, and theophylline as described (11) . Megakaryocytes were isolated from marrow cell suspensions by an albumin (bovine serum albumin, fraction V, Armour Pharmaceutical Co., Kankakee, Ill.) density gradient centrifugation, followed by two successive velocity sedimentations, as described (10, 11) . The isolated megakaryocytes had been washed nine times by the completion of the separation procedures, and the other fractions six times. The cell fractions discarded after each step (the pellet in the density separations and the upper portion of the velocity sedimentations) contained modest numbers of megakaryocytes. These cell populations were saved for study, and are designated the waste cell fractions. The numbers of megakaryocytes, total cells, and platelets present were counted in each slispension by phase-contrast microscopy at x250. Megakaryocytes were identified by their size, ntclear configuration, and prominent light refraction.
Samples were prepared for growth factor assay by suspending the cells from the various pellets in phosphatebuffered saline, and then lysing the cells by freezing and thawing six times in dry ice-acetone. The lysates were heated at 56°C for 30 min and precipitated protein was removed by centrifugation. The supemates so obtained are referred to as lysates in this paper, and were assayed immediately after their preparation. PPP, when used in assays, was heat treated in a similar fashion. Protein content was estimated by the methods described (12, 13) , and dilutions were made with phosphate-buffered saline.
Growth (2) . The experimental data were converted to arbitrary units of growth factor activity for convenience of quantitative expression, as described in detail elsewhere (4) . In brief, the amount of growth factor activity in each test sample was measured by comparing it to the growth-prompting activity obtained with fetal calf serum (FCS, Gibco Laboratories, Grand Island Biological Co., Grand Island, N. Y.). To make such a comparison, a dose-response curve was determined in each experiment both for FCS and for each test sample. The doseresponse data were plotted semi-logarithmically, and one unit of growth factor activity was defined as the activity obtained with 1% FCS (in terms of the percentage of the activity obtained with 10% FCS). For each test sample, the amount of sample that exhibited 1 U of growth factor activity (as determined from the FCS dose-response data) was determined from a semi-log plot of the dose-response data for the sample. In making these determinations, linear regression analyses were performed on those data comprising the linear portions of the semi-log plots. Finally, from the results obtained, the number of cells in a sample possessing 1 U of growth factor activity was determined.
RESULTS
A preliminary experiment was conducted to determine whether guinea pig platelets possessed growth factor activity that was measurable in the bioassay developed for human PDGF. After lysis of unwashed platelets that were pelleted from platelet-rich plasma, distinct growth factor activity was observed, at a level of 10.4 U/109 platelets.
Experiments were next conducted to compare the growth factor activity of washed platelet lysates to that of megakaryocyte lysates (from different animals), with or without supplemental guinea pig PPP (2 mg protein/dish). In two experiments, in the presence of PPP, the platelet lysate activities were 10.2 and 16.2 U/109 platelets, respectively, and the corresponding megakaryocyte activities were 11.0 and 14.5 U/106 megakaryocytes. Thus, under those conditions the isolated megakaryocytes contained distinct growth factor activity, comparable to that contained in -103 times as many platelets.
Even in the absence of PPP, the level of growth factor activity derived from megakaryocytes was of the order of that derived from 103 times as many platelets, although much lower growth factor activities were observed under these conditions. In the two experiments described above, in the absence of PPP, slightly <1 U of growth factor activity was observed per 109 platelets or per 106 megakaryocytes. These findings are similar to observations recently reported for human PDGF, that have demonstrated a synergistic interaction between PDGF and plasma-derived factors, that affects the amount of biological activity observed for a given amount of PDGF (1, 14, 15) . 2 Megakaryocytes comprised 64% of the cell number and -98% of the mass of the cell pellets from which the megakaryocyte lysates were prepared (10, 11) . It was possible, however, that a significant portion of the growth factor activity observed in the megakaryocyte lysates might have arisen from contaminating, nonmegakaryocyte cells. Accordingly, two additional experiments were conducted to compare lysates prepared from megakaryocytes to those from the waste cell fractions (i.e., the cells removed from the marrow cell suspensions during the various stages of megakaryocyte isolation). The results of these two experiments are shown in Figs. 1 and 2 . Fig. 1 shows the dose-response curves obtained with lysates prepared from purified megakaryocytes, from the first and second velocity waste cell fractions, and from washed platelets (from the same animals). Both the platelet and the megakaryocyte lysates showed a progressive increase in growth factor activity with an increase in the number of cells from which the amount of lysate tested had been obtained. By contrast, no such relationship was observed between growth factor activity and the cell number of the lysates from the first and second velocity waste fractions, and the growth factor activity of these fractions remained low, over the range of cell numbers tested (Fig. 1) . Thus, of the narrow-derived cells, only the purified megakaryocyte 2 We have foutnd that the mitogenic activity of htuman platelet lysates is increased by as miuiclh as 10-15-fold by adding 2% PPP seruim to the incubation mediulm. Cherinoff, A., and D. S. Goodman. Unpublished observation. fraction possessed considerable amounts of growth factor activity. Moreover, the dose-response curves obtained with the megakaryocyte and platelet lysates were roughly parallel to each other (Fig. 1) . In this experiment, the potency of the purified megakaryocytes was 3.9 U of growth factor activity per 106 megakaryocytes, compared to 0.8 U/109 platelets. Fig. 2 shows the results of a second, similar experiment, in which the level of observed growth factor activity was related to the logarithm of the number of megakaryocytes present in each cell fraction. There was a high correlation (r = 0.82, P < 0.001) between the growth factor activity observed in a given cell fraction and its megakaryocyte content. The specific activities (units/106 megakaryocytes) calculated for the various marrow fractions were all of the same order of magnitude (varying from 1.5 to 6.2 U/106 megakaryocytes), despite the fact that the proportion of megakaryocytes (percentage of all marrow cells) varied almost three orders of magnitude in the different fractions. These data suggest that the growth factor activity present in guinea pig marrow is derived almost exclusively from the megakaryocytes. limited data, have varied from about 2 to 11 x 103 (16) . In one experiment, we determined the total protein content of pellets of isolated megakaryocytes and of washed platelets from the same guinea pigs. The total protein contents observed were 1.46 mg/106 megakaryocytes and 1.45 ,ug per 106 platelets (means of two animals), representing a ratio of 1,000 platelets to one megakaryocyte in terms of total protein content. A second, morphometric study was also conducted to estimate the number of platelets in one megakaryocyte. From a fortuitous section of guinea pig bone marrow, an electron micrograph was made (17) of a fully mature megakaryocyte in which the cytoplasm was completely divided into platelets; shedding was probably imminent at the time of fixation. The size of this cell (26 x 42 ,um) seemis to be typical for a fully mature megakaryocyte. In one thin section, 233 discrete platelets were counted. Using 2.1 p.m as the thickness of these nondiscoid platelets, and Harker's calculation (18) for extrapolation from one section to the content of the entire ellipsoid, a total platelet count of 2,560 was estimated for this cell. This result is comparable to the protein content ratio (above), when one considers that the pool of isolated megakaryocytes comprised immature, developing, and fully mature cells, and that the latter alone would be expected to have a higher ratio of protein content (compared to platelets) than the isolated pool. Thus, the ratio of growth factor activities in megakaryocytes and platelets, which ranged from about 1,000 to 5,000, appears to be quantitatively similar to the number of platelets that are derived from a single megakaryocyte.
DISCUSSION
The 3T3 cell bioassay for growth factor activity has proven to be a useful quantitative assay for human PDGF under a variety of experimental circumstances (2-5). As reported here, this sensitive bioassay is not stringently limited by problems of species specificity. Thus, the same bioassay developed for human PDGF could be used to detect and measure growth factor activity in the lysates of guinea pig platelets and megakaryocytes.
Human PDGF interacts synergistically with lhuman PPP (1, 14, 15) .2 Thus, it has been reported that maximal cell growth re(quires the presence both of platelet factors, which recruiit quiescent cells into the cell cycle, and also of optimal amounts of plasma factors, which permnit recruited cells to progress through the cell cycle (14, 15) . The results reported here suggest that the growth factor activities present in both guinea pig platelets and megakaryocytes also demonstrate this biologic property of interacting synergistically with PPP.
The level of PDGF activity in guinea pig platelets, as imeasured in the bioassay used here, was approximately an order of imiagnitude less than that observed with humani platelets, both in the absence and presence of PPP (4) . At 
